Document:

Converted by EDGARwiz

TECHNOLOGY PURCHASE AGREEMENT

This Agreement made this  18th  day of May, 2004.

                                  

                                 And amended this 16th day of May, 2005

BETWEEN:

QV VENTURES LTD., a British Columbia corporation having a Registered and Records Office located at: 700-625 Howe Street, Vancouver BC, V6C 2T6

(hereinafter referred to as the "Purchaser")

OF THE FIRST PART

AND:                           3493734 MANITOBA, LTD. A Manitoba corporation

 having a place of business located at:

387 Broadway

 Winnipeg, Manitoba

Canada, R3C 0V5

(hereinafter collectively referred to as the "Vendor")

OF THE SECOND PART

WHEREAS the Vendor has developed certain information, expertise, know-how, 

show-how related to a proprietary Soft Ware Program, marketed under the trade 

name “MediFlow”.  (collectively referred to as the “Technology”).

AND WHEREAS the Vendor has utilized the Technology to develop and market 

this Soft Ware Program/ Medical search engine.

AND WHEREAS the Vendor wishes to sell and the Purchaser wishes to 

                       purchase the Technology and related Software programs.

NOW THEREFORE this Agreement witnesses that in consideration of the 

premises, and of the mutual covenants and agreements herein contained and other 

good and valuable consideration, the receipt and sufficiency of which is hereby 

acknowledged the parties hereto have agreed to and do hereby agree as follows:

1.

DEFINITIONS

1.1

In this Agreement, unless a contrary intention appears, the following words and phrases 

            shall mean:

a.

“Technology” means and shall include any Patents and all of the information, data, schematics blueprints, drawings, registered and unregistered trademarks, trade-names, copyrights, designs expertise, and know-how of every nature and kind related to this Soft Ware Program, held by the Vendor either directly or indirectly and shall include any improvements modifications or variations thereto.

            b. "Net Sales Revenue" shall have the meaning as set out in Schedule "A"

                        c. “Development work” shall have the meaning as set out in Schedule “B”

 

2.

PURCHASE AND SALE OF ASSETS

0.1

     Upon the terms and subject to the conditions hereof, the Purchaser agrees to 

              purchase, and the Vendor agrees to sell, assign and transfer to the Purchaser the 

              Technology. 

0.1

the parties shall, enter into such further agreements and execute any and all 

            documents as may be necessary and reasonably required to ensure that ownership of the 

            Technology vests and remains with the Purchaser. 

3.

PURCHASE PRICE

0.1

      The Vendor agrees to sell and the Purchaser agrees to purchase the Technology from the 

             Vendor for the following consideration:

a.

The sum of FIVE THOUSAND USD ($5,000) USD payable upon execution

      of this agreement, and 

b.

ONE HUNDRED THOUSAND (100,000) Common Shares in the capital

      stock of the Purchaser on the Closing Date; and

c.

 A royalty of TWO (2%) PERCENT calculated on the Net Sales Revenue of any product that uses all or any portion of the Technology until, development costs incurred to date have been recovered to a maximum of USD TWO HUNDRED FIFTY THOUSAND ($250,000) DOLLARS. After which the royalty shell be reduced to ONE (1%) PERCENT; and

d.

TWO HUNDRED FIFTY FIVE THOUSAND USD ($255,000)

In additional Software development costs to be managed and led

by the vendor, providing the vendor remains competitive in their 

pricing of future development work and in conjunction with

Schedule ”B”.

a.1

      The royalty shall be paid quarterly in arrears following the first commercial sale 

             of products incorporating the Technology. 

4.

TAXATION

a.1

The Purchaser and the Vendor shall take such steps and execute such documents, and 

            certifies and makes such elections pursuant to the Canada Customs and Revenue Agency 

            (CCRA) as may be required in order to affect the transfer of the Technology in a tax 

             efficient manner such that the minimum tax liability will accrue to the parties.

a.2

The Vendor and the Purchaser covenant and agree that the purchase price of the Assets 

            will be the aggregate fair market value thereof and further covenant and agree that if the 

           CCRA or any other competent authority at any time proposes to issue or issues any 

            assessment or assessments that would impose or imposes any liability for tax of any

            nature or kind on any of the parties hereto or on any other person on the basis that the 

            aggregate fair market value of the property transferred herein is greater or lesser than the 

            amount stipulated in paragraph 3 hereof (hereinafter referred to as the "Stipulated 

            Amount"), and in the event that the parties agree, or a competent tribunal finally adjudges 

            that the aggregate fair market value of the property is a greater or lesser amount 

            (hereinafter referred to as the "Adjusted Amount") than the Stipulated Amount, then the 

            redemption amount in respect of the preferred shares in the capital stock of the Purchaser 

            will be determined by reference to the Adjusted Amount to the exclusion of the 

            Stipulated Amount and the Vendor and the Purchaser will do all such things and perform 

            all such acts as may be necessary to revise the redemption amount accordingly.

5.                     CLOSING 

5.01

The closing of the transaction of sale and purchase hereunder will take place on May , 2004 at the business offices of Gregory Yanke, Barrister and Solicitor of Vancouver British Columbia at  1:00p.m. (the "Closing Date").

6.

REPRESENTATIONS AND WARRANTIES

a.1

The Vendor represents and warrants to the Purchaser (and acknowledges that the 

             Purchaser has relied upon such representations and warranties in entering into this 

             Agreement) that except as disclosed herein:

a.

the Vendor has the power and capacity to own and dispose of the assets and to enter into this Agreement and to carry out its terms to the full extent;

b.

there are no actions, suits, judgments, litigation proceedings or investigations outstanding, pending or to the knowledge of the Vendor threatened against the technology , nor does the Vendor know  or have any reasonable grounds or know of any basis for any such actions, suits, litigation proceedings or investigations;

c.

all material transactions of the business have been properly and promptly recorded or filed in or with its respective books and records and the minute books of the business contain complete records of all meetings and proceedings of the Shareholders and Directors;

d.

the execution and delivery of this Agreement and the completion of the transactions contemplated hereby have been duly and validly authorized by all necessary corporate action on the part of the Vendor, and this Agreement constitutes a legal, valid and binding obligation of the Vendor enforceable against the Vendor in accordance with its terms except as may be limited by laws of general application effecting the rights of creditors and by general principals of equity;

e.

the Vendor warrants and represents that the Vendor has good and marketable title to the Technology and the Technology is free and clear of all liens, mortgages, charges, pledges, security interests, encumbrances or other claims whatsoever, other than leases and encumbrances disclosed herein;

f. 

the Vendor has taken all necessary and proper steps to register and to keep the patent in good standing and the vendor is not aware of any conflicting claims or patent applications .

g.

the Vendor is the sole owner of any copyright, patent, trademark, etc. and no other person(s) or party has advanced a claim of ownership or claiming an interest in the product, nor is any claim likely to be made in the future to the knowledge of the Vendor and there have been no legal proceedings or threats of legal proceedings of which involving the product of which the Vendor is aware.

h.

neither the execution nor delivery of this Agreement nor the completion of the transactions contemplated hereby shall;

                      

i.

Violate any of the terms and provisions of any order, decree, statute, by- 

            law or regulation agreement, covenant or restriction applicable to the 

            Vendor;

j.

the Vendor represents and warrants to the Purchaser and acknowledges that the Purchaser has relied upon same that the Vendor owns and has full and clear title to the Technology;

6.02

The Purchaser represents and warrants to The Vendor (and acknowledges that the Purchaser has relied upon such representations and warranties in entering into this Agreement) that except as disclosed herein:

(a)

the  company is duly organized, existing, in good standing and has the power, authority, and capacity to enter into this Agreement and to carry out the transactions contemplated by this Agreement, all of which have been duly and validly authorized by all requisite corporate proceedings

i.1

From the date hereof until the closing the Vendor shall diligently and in the manner of a 

            prudent business person in the ordinary course of business and will use its best efforts to 

            preserve the Technology.

7.

INDEMNIFICATION CLAUSE

.1

The Vendor covenants and agrees to indemnify and hold harmless the Purchaser 

                        from and against:

a.

any and all losses, damages or deficiencies resulting from any misrepresentation, breach of warranty or non-fulfilment of any covenant on the part of the Purchaser under this Agreement or from any misrepresentation or omission from any certificate or other instrument, furnished or to be furnished from the Company hereunder; and

b.

all actions, suits, proceedings, demands, assessments, judgments, costs and legal and other expenses incidental to any of the foregoing, the cause of action, subject matter, or basis of which arose prior to March 1, 2004

                         and the Purchaser may, on notice in writing to the Vendor, settle such claims and 

                         make any payment in relation thereof as the Purchaser sees fit.

.2

The Purchaser covenants and agrees to indemnify and hold harmless the Vendor from and against:

a.

any and all losses, damages or deficiencies resulting from any misrepresentation, breach of warranty or non-fulfilment of any covenant on the part of the Vendor under this agreement, or from any misrepresentation in or mission from any certificate or other instrument, furnished or to be furnished from the Company hereunder; and

b.

all actions, suits, proceedings, demands, assessments, judgments, costs and legal and other expenses incidental to any of the foregoing, the cause of action, subject matter, or basis of which arose after May 1, 2004.

                            and the Vendor may, on notice in writing to the Purchaser, settle such claims 

                            and make any payment in relation thereof as the Vendor sees fit.

8.

SURVIVAL

.1

Notwithstanding any enquiry or investigation by the Purchaser, the representation and 

            warranties of the Vendor contained in this agreement shall survive its closing of the 

            transactions contemplated by this agreement and shall continue in full force for the 

            benefit of the Purchaser thereafter.

9.

NON-COMPETITION

9.01

The Vendor shall not, for a period of Three (3) years from the Closing Date, individually or in partnership or jointly or in conjunction with any company / person as principal, agent, employee, contractor, landlord, consultant, supplier, lender, financier, shareholder, or in any other manner, directly or indirectly, engage in, carry on or provide services to, be employed by or have an interest in, or otherwise be concerned with any other business in Canada and the United States of America which offers services or sells products that compete with the services and products resulting from the Technology whatsoever.

10.

ENTIRE AGREEMENT

10.01

This agreement constitutes the entire agreement between the parties hereto relating to the subject matter hereof and supersedes all prior and contemporaneous agreements, understandings, negotiations and discussions, whether oral or written, of the parties and there are no general or specific warranties, representations or other agreements by or among the parties in connection with the entering into of this agreement or the subject matter thereof except as specifically set forth herein.

11.

SEVERABILITY

11.01 If any provisions of this agreement are held unenforceable or invalid by a Court of competent jurisdiction, the parties hereto acknowledge and agree that the enforceability or validity of the remaining provisions shall not be affected thereby.

12.

JURISDICTION

12.01

This agreement shall be governed by and in construed accordance with the laws of the State of Nevada and the parties hereto hereby submit to the jurisdiction of the Courts of the State of Nevada.

13.

TIME OF THE ESSENCE

.1

Time shall be of the essence in this agreement.

13.02   This agreement may be executed in counterpart and by facsimilie

14.

ENUREMENT

14.01

This agreement shall enure to the benefit of and be binding upon the parties hereto and their respective successors and permitted assigns.

IN WITNESS WHEREOF THE PARTIES have hereunto set their hands and Corporate Seals, duly attested to be the hands of their properly authorized officers in their behalf on the day and year first above written.

Signed for and on behalf of

3493734 MANITOBA LTD.

By its authorized signatory

Per: /s/ Larry Cherrett

Authorized Signatory

SIGNED, SEALED AND DELIVERED

)

By QV VENTURES, LTD. in the presence of:)

)

)

Name

)

)

Address

)         Per: /s/ Desmond Ross

)

Occupation

)

Desmond Ross, President

2

SCHEDULE "A"

"Net Sales Revenue":  all revenues, receipts, monies and the fair market value of all other considerations, directly or indirectly collected or received, whether by way of cash or credit or any barter, benefit, advantage, or concession received by the Company or its affiliate companies from marketing, manufacturing, sale, or distribution of the products that incorporate all or a portion of the Technology, world wide less the following:

(i)

trade and quantity discounts actually given to the purchasers thereof to a maximum discount of 60%;

(ii)

all government taxes customs and excise, sales and value added taxes and other charges or governmental fees of every nature or kind (except for taxes on or measured by income);

(iii)

transportation and insurance charges and commissions in connection with the sale of Products; and

(iv)

credit allowances or refunds given on account of returned goods, up to a maximum of 5% of Net Sales Revenue.

                                                                SCHEDULE “ B”

                       Development work will comprise of all work related to the furtherance of the 

                       Mediflow  software program which may include: testing, upgrading the existing

                       Software,  preparation of and submitting applications  to government agencies for

                       funding in the form of grants or loans or a combination of both, development of 

                       web and demonstration sites, Marketing of the program and any considerations 

                       both directly  associated with the advancement of the Mediflow software program.

a.

Prior to the purchaser becoming a reporting issuer, the purchaser will be 

      responsible for the following :   

        i.        Commencement of the trade marking process

                                 ii.       Commencement of web design and construction of a Website

        iii       Submitting application to Government  Agencies for Funding

b.

Upon  the purchaser becoming a reporting issuer,  the purchaser

Will be responsible for the following within the first year:

i.

Completion of both web and demonstration sites

ii.

Commence and  complete initial upgrades to the soft ware program

iii.

Engage a Marketing firm specializing in Marketing software applications.

iv.

Spend a minimum of $50,000 to a maximum of $100,000   

c.

During the second year the purchaser will be responsible for the following:

          

i.

Continue to upgrade the software on a regular basis, which may

             need to upgraded on a weekly , bi-weekly or monthly basis.

ii.

Continue to aggressively market the software through a marketing 

            firm specializing in marketing software application.

iii.        spend a minimum $100,000.Non Disclosure and Confidentiality Agreement

                                                                     EXHIBIT 10.2  

Non-Disclosure and Confidentiality Agreement

               The undersigned acknowledges that, _____________, or an affiliated or designated entity 

of (“QUANTUM”) has or will furnish to the undersigned, its agents, employees, members, representatives and affiliates ("Recipient") certain proprietary data relating to the business affairs and operations of the business of the company, including but not limited ________________________for study and evaluation by the Recipient of the company’s business.   It is acknowledged by the Recipient that the information provided by QUANTUM is confidential; therefore, the Recipient agrees not to disclose it and not to disclose that any discussions or contracts with QUANTUM have occurred or are intended, other than as provided for in the following paragraph. 

It is acknowledged by the Recipient that information to be furnished is in all respects confidential in nature, other than information which is in the public domain through other means and that any disclosure or use of same by Recipient, except as provided in this Agreement, may cause serious harm or damage to QUANTUM. Therefore, the Recipient agrees that the Recipient will not use the information furnished for any purpose other than as stated above, and agrees that the Recipient will not either directly or indirectly by agent, employee, or representative, disclose this information, either in whole or in part, to any third party; provided, however that (a) information furnished may be disclosed only to those members, officers and employees of the Recipient (including affiliates and parent companies) and to the Recipient' advisors or representatives who need such information for the purpose of evaluating any possible transaction (it being understood that those members, officers, employees, advisors, affiliates, parent companies, and representatives shall be informed by the Recipient of the confidential nature of such information and shall be directed by the Recipient to treat such information confidentially), and (b) any disclosure of information may be made to which QUANTUM consents in writing. At the close of negotiations, the Recipient will return to QUANTUM all records, reports, documents, and memoranda furnished and will not make or retain any copy thereof. 

During the period of due diligence and preparation for such business opportunity and for a period of one (1) year thereafter, regardless of the reason for the Recipient’s cessation of due diligence and preparation with QUANTUM, the Recipient shall not, on his or her own behalf or on behalf of any person, firm or corporation, or in any capacity whatsoever, (i) solicit any persons or entities with which QUANTUM or the Company had contracts, was negotiating contracts, or was affiliated with QUANTUM for any transaction related to the business opportunity introduced by QUANTUM,  or (ii) induce, suggest, persuade or recommend to any such persons or entities that they terminate, alter or refrain from renewing or extending their relationship with QUANTUM, and the Recipient shall not induce or permit any other person to, approach any such person or entity for any purpose. Should Recipient become aware that any other party included hereunder or third party has engaged in such conduct, Recipient agrees to immediately advise QUANTUM of the circumstances of such conduct.  The breach or threatened breach by Recipient of any of the provisions of this Agreement shall entitle QUANTUM to a permanent injunction and other equitable relief, without the requirement to post bond, in order to prevent or restrain any such breach or threatened breach by the Recipient or the Recipient’s partners, agents, representatives, servants, independent contractors, affiliates, parent company or any and all persons or entities directly or indirectly acting for or with the Recipient. The rights and remedies of QUANTUM under this Agreement shall be in addition to and not in limitation of any of the rights, remedies, and monetary or other damages or redress available to it at law or equity.  This Agreement shall survive the cessation  between the parties.

_________________________________

 ____________

Signature 

       Date

________________________________

Name (typed or printed)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}]]